Welcome to listen to our speak!

Wednesday, March 23, 9:30 PDT (17:30 CET)

"Development of an iLite^® Reporter Cell Platform for the Quantification of Anti-AAV Neutralizing Antibodies"

PRESENTED BY:
Jordi Rodó, Research Scientist

Join our presentation!

We are thrilled to be included in the scientific agenda on day three. We will be joining with a presentation on the session topic: Potency Assay Method Development-Case Studies.

Don't miss this opportunity to listen to our Research Scientist, Jordi Rodó, as he presents live from Sweden!

The BioPharmaceutical Emerging Best Practices Association (BEBPA) is managed by, and for the benefit of, the biopharmaceutical scientific community.

BEBPAs' aim is to promote development of innovative approaches and solutions to facilitate safer and faster biopharmaceutical product development.

It provides an international forum for the presentation and discussion of scientific issues, and problems, encountered in the biopharmaceutical community.